Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

BACKGROUND: Patients with treated solid tumours (TSTs) are a highly heterogeneous population at an increased risk for malignancy compared with the general population. When treating psoriasis in patients with a history of TSTs, clinicians are concerned about the immunosuppressive nature of psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Kim A., Melosky, Barbara, Sehdev, Sandeep, Hotte, Sebastien J., Beecker, Jennifer R., Kirchhof, Mark G., Turchin, Irina, Dutz, Jan P., Gooderham, Melinda J., Gniadecki, Robert, Hong, Chih-ho, Lambert, Jo, Lynde, Charles W., Prajapati, Vimal H., Vender, Ronald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060504/
https://www.ncbi.nlm.nih.gov/pubmed/36929121
http://dx.doi.org/10.1007/s13555-023-00905-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060504/
https://www.ncbi.nlm.nih.gov/pubmed/36929121
http://dx.doi.org/10.1007/s13555-023-00905-3

Ejemplares similares